Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
29%
OVERLAP
BY WEIGHT
3
# OF OVERLAPPING
HOLDINGS
PPH
27
HOLDINGS
13%
ALSO IN OZEM
OZEM
21
HOLDINGS
14%
ALSO IN PPH
SECTOR DRIFT (PPH minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 22.3% | 18.2% | 18.2% |
 |
NOVO-NORDISK A/S-SPONS ADR | 5.9% | 13.1% | 5.9% |
|
PFIZER INC | 4.8% | 6.4% | 4.8% |
PPH Overweight Relative to OZEM
 |
NOVARTIS AG-ADR | 10.5% |
|
MERCK & CO. INC. | 9.5% |
|
BRISTOL-MYERS SQUIBB CO | 4.3% |
 |
SANOFI-AVENTIS-ADR | 4.3% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | 4.2% |
|
ELI LILLY & CO | 4.2% |
|
ASTRAZENECA PLC-SPONS ADR | 4.1% |
|
ABBVIE INC | 4.1% |
|
JOHNSON & JOHNSON | 4.0% |
|
MCKESSON CORP | 3.6% |
PPH Underweight Relative to OZEM
|
NOVO-NORDISK A/S-SPONS ADR | -7.2% |
|
VIKING THERAPEUTICS, INC. | -4.8% |
 |
CHINA PHARMACEUTICAL GROUP | -4.5% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.3% |
|
ZEALAND PHARMA A/S | -4.1% |
 |
HANMI PHARM CO LTD | -4.0% |
 |
INNOVENT BIOLOGICS, INC. | -4.0% |
|
AMGEN INC | -3.5% |
 |
ASCLETIS PHARMA, INC. | -3.3% |
|
ASTRAZENECA PLC | -3.3% |